Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1986;64(4):355-77.
doi: 10.1007/BF00212059.

Effects of aldose reductase inhibition on the retina and health indices of streptozotocin-diabetic rats

Affiliations

Effects of aldose reductase inhibition on the retina and health indices of streptozotocin-diabetic rats

W M Kozak et al. Doc Ophthalmol. 1986.

Abstract

Experiments were performed on Streptozotocin-diabetic rats to investigate the preventive effect of an aldose reductase inhibitor, Sorbinil, on the deterioration of electroretinograms and retinal tissue that normally occurs during diabetes, and to determine Sorbinil's effect on the general health indices: food and water intake, urine glucose and ketones, body weight, and blood glucose levels in diabetic rats. Two dosages of Sorbinil were tested, 60 mg/kg/24 hours and 10 mg/kg/24 hours. Electroretinograms and the above health indices were measured before injection of Streptozotocin and again after a three week period of diabetes. Sample eyes were then examined by electron microscope and the thickness of the retinal capillary basement membranes was measured. Statistical evaluation showed that Sorbinil-treated diabetic rats did not experience the same lengthening of latencies and reduction in amplitude of various electroretinogram components that occurred in non-treated diabetic rats. Sorbinil improved the general health of diabetic rats and reduced their mortality rates as well. Preliminary electron microscope studies showed a correlation between thickness of the retinal capillary basement membrane and various electroretinogram parameters.

PubMed Disclaimer

References

    1. Brain Res. 1982 May 6;239(1):271-4 - PubMed
    1. Nippon Ganka Gakkai Zasshi. 1974 Aug;78(8):636-48 - PubMed
    1. N Engl J Med. 1983 Jan 20;308(3):119-25 - PubMed
    1. Ophthalmologica. 1974;168(2):97-108 - PubMed
    1. JAMA. 1981 Jul 17;246(3):257-61 - PubMed

Publication types